Open Innovation in Life Science R&D, Vienna (Austria)
Open Innovation in Life Science R&D, Vienna (Austria)
12-13th October, 2011, Vienna, Austria. Maximising R&D productivity & minimising risk through efficient management of more-open & competitive collaborations & alliances.
"Open-innovation" is a concept that has been discussed a lot in recent times across many knowledge-intensive high-tech industries, including one as innovation-dependent as the global life sciences industry. The idea of pooling risk, costs and resources, whilst hopefully increasing R&D productivity at the same time through collaborative innovation is attractive in theory, although difficult in practice in an industry when IP protection is paramount.
Why Attend?
• Understand what is meant by "open-innovation" in practice and how this can work in life sciences.
• Hear real-life examples of successful implementation from pharmaceutical companies, academic-led consortia, non-profits and public-private partnerships.
• Appreciate if the benefits outweigh the costs, as well as answers to the questions what? With who? When? Why? How? And how much?
• Determine how best to share information, risks and costs with R&D partners, whilst protecting intellectual property and maximising the benefits of joint synergies.
